The changing epidemiology of severe infections in the ICU  by Wolff, Michel et al.
The changing epidemiology of severe infections in the 
ICU 
Michel Wolf, Christian Bvun-Buisson2, Hartmut Lode3, Dilip Mathai4, David Lewis 
and Didier Pittet6 
lHBpital Bichat - Claude-Bernard, Clinique de Rtanimation des Maladies Infectieuses, Paris, France; 
2Services de Rtanimation Medicale, HBpital Henri Mondor, Crtteil, France; 3Krankenhaus 
Zehlendorf, Pneumologie, Infektiologie and Irnmunologie, Berlin, Germany; 4Department of 
Medicine, Christian Medical College Hospital, Vellore, Tamil Nadu, India; 5Hospital Sao Paulo, 
Federal University Infectious Disease Division, Sao Paulo, Brazil; 6Infection Control Program, 
Department of Internal Medicine, HBpitaux Universitaires de Geneve, Geneva, Switzerland 
Data on the epidemiology of severe infection in the intensive care unit (ICU) can be used to monitor the effect of preventive 
measures and changes in policy or procedures. The most common risk factors associated with ICU-acquired infection 
include length of stay, antibiotic usage, catheterization and use of other invasive devices. The most frequent infections 
encountered in ICU patients include lower respiratory tract infections (especially pneumonia) and bacteremia, in addition 
to urinary tract infections and wound infections. Streptococcus pneumoniae, Haemophilus influenzae, methicillin- 
susceptible Staphylococcus aureus and Enterobacteriaceae are most often implicated in community-acquired and early 
onset ICU-acquired infections, whereas late onset infection is more likely to  be caused by pathogens which are more 
refractory to treatment, such as Enterobacter spp., Serratia spp., Pseudomonas aeruginosa, Acinetobacter spp. and 
methicillin-resistant S. aureus (MRSA). The pathogen spectrum also varies according t o  the site of infection, with Gram- 
positive bacteria being most frequently isolated in bacteremia and wound infections, whereas Gram-negative bacteria are 
prevalent in late-onset pneumonia and urinary tract infections. The prevalence of Gram-positive pathogens in bacteremia 
has increased over the past 20 years, mainly because of the increased isolation of coagulase-negative staphylococci (CNS) 
and enterococci. This is most probably due to the selective pressure exerted by the use of broad-spectrum antibiotics, 
such as the third-generation cephalosporins and fluoroquinolones, which are generally more potent against Gram- 
negative than Gram-positive bacteria, and to the increased use of invasive devices. 
The increasing isolation frequency of Gram-positive pathogens in severe ICU infections has resulted in greater usage 
of vancomycin, which may account for the rising incidence of vancomycin-resistant enterococci. 
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INTRODUCTION 
Adequate infection control and antibiotic prescribing 
policies rely on data based on the epidemiology of 
infections. Patients in the intensive care unit (ICU) 
may be admitted with community-acquired infection 
or may become infected after admission. 
However, the definition of the concept of 
community- compared with hospital-acquired 
infection may be challenged in some clinical settings 
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since more patients, such as HIV positive or other 
immunocompromized patients. For example, a high 
fi-equency of apparent ‘community-acquired’ infections 
caused by Pseudomonas aevuginosa has been reported 
recently [l]. Many of these patients were probably 
contaminated with hospital strains in day-care 
facilities or  during previous hospital stays. In 
addition, the definition of  early versus late 
nosocomial-acquired infections has been more or less 
arbitrary [2,3]. 
Nosocomial infection is associated with increased 
mortality, morbidity, length of hospital stay and cost 
of treatment [4]. In a matched case-control study of 
surgical ICU patients, the crude mortality of patients 
with nosocomial bloodstream infection was 50% and 
the attributable mortality due to the infection was 
35% (95% CI 5 25-45%) [ 5 ] .  Cases with bloodstream 
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infection stayed eight days longer in the ICU and 24 
days longer in hospital than matched controls without 
infection, with associated attributable costs of more 
than US $40,000 per survivor. Similar results have 
been found in other studies of nosocomial infections, 
highlighting the economic importance of adequate 
management of patients with sepsis [6]. 
Critically ill patients are at higher risk of acquiring 
infection because of more serious underlying 
conditions and greater use of invasive procedures [7]. 
The important parameters that need to be monitored 
are: the predominant types of infection encountered 
in ICU patients, risk factors associated with the 
acquisition of these infections, pathogen prevalence 
and the transfer between ICUs (within and outside 
the hospital) and the antibiotic susceptibilities of these 
pathogens. A number of recent reports have examined 
the epidemiology of serious infections in I C U  
patients [8-141 and the current situation is discussed in 
this paper. 
RISK FACTORS FOR INFECTION IN THE ICU 
The results of the European Prevalence of Infection in 
Intensive Care (EPIIC) study, the first large study in 
Europe to examine the prevalence of nosocomial 
infection and associated risk factors in ICU, were 
published in 1995 [8]. The study included 4501 
patients who had one or more infections on the study 
day (44.8% of the total patient population). 
Community-acquired infection was recorded in 1376 
cases (13.7%), hospital-acquired infection in 975 
(9.7%) and ICU-acquired infection in 2064 cases 
(20.6%) of the total patient population. 
Although there was a marked variation in the 
incidence of infection in the 17 countries participating 
in EPIIC, a significant correlation (R2 = 0.68) was 
noted between the prevalence of ICU-acquired 
infection and the mortality rate; likewise, mortality 
was linked with acquired pneumonia, bacteremia and 
sepsis after multivariate analysis. Predisposing risk 
factors associated with ICU-acquired infection 
were: prolonged length of I C U  stay, antibiotic 
usage, mechanical ventilation, pulmonary artery 
catheterization, central venous access, stress ulcer 
prophylaxis, urinary catheterization, the use of steroids 
and nutritional status. Thus, many factors may 
influence the microbial etiology of sevsere infections in 
ICU. This paper will focus on the length of stay, that 
is the duration of exposure to risk, arid on the usage 
of antibiotics. Risk factors such as mechanical 
ventilation and neutropenia will be discussed later in 
the supplement [15,16]. 
Duration of stay 
The length of stay in the ICU is a major risk factor for 
all nosocomial infections [7]. In the EPIIC study, 
patients who had been in the ICU for 3-4 days were 
three times more likely to acquire an infection than 
those who had been admitted for 1-2 days. The risk 
increased two-fold for patients who had been in the 
ICU for 5-6 days and those who had been in the 
ICU for a t  least 21 days were 33 times more likely to 
be infected than those who had been there for 1-2 
days [8] .  
The duration of stay in the ICU also influences the 
pathogens involved. In general, community-acquired 
infections and early hospital-acquired infections (i.e. 
those acquired I 4 days after admission) are more 
often caused by Streptococcus pneumoniae, Haemophilus 
injuenzae, Enterobacteriaceae such as Escherichia coli, 
Proteus spp. and Klebsiella pneumoniae, methicillin- 
susceptible Staphylococcus aureus, streptococci and 
anaerobes. In contrast, late hospital-acquired infections 
(acquired > 4 days after admission) are more often due 
to high-risk resistant organisms such as Entevobacter spp., 
Serratia spp., organisms producing extended-spectrum 
p-lactamases (ESBLs) , P. aeruginosa, Acineto6acter spp., 
methicillin-resistant Staphylocoi-cus auveus, enterococci 
and fungi [2]. In a recent outbreak of ESBL-producing 
Enterobacteriaceae in a French ICU, it was shown 
that the risk for acquiring these pathogens increased 
during the ICU stay from 4.2% in the first week to 
24% in the fourth week [17]. 
Antibiotic usage 
There is no doubt that increasing antimicrobial 
resistance has followed the introduction of new 
antibiotics [ 18-25] and many nosocomial organisms 
have acquired multidrug resistance. The prevalence of 
antimicrobial-resistant human pathogens is rapidly 
increasing, but the discovery and development of new 
antibacterial agents that are active against multidrug- 
resistant organisms have slowed dramatically [26]. 
Critically ill patients constitute major reservoirs for 
multi-resistant organisms and resistance spread is 
common in ICUs where the majority of outbreaks of 
nosocomial transmission have been described. The 
issue of resistance in nosocomial pathogens is covered 
in more detail elsewhere in this supplement [25]. 
Previous exposure to antibiotics may favor the 
emergence of multi-resistant pathogens by two main 
mechanisms. Firstly, antibiotics may modift. intestinal 
flora, leading to colonization with resistant bacteria. 
For example, third-generation cephalosporins [27], 
fluoroquinolones and vanconiycin [28] have been 
found to be risk factors for colonization and/or 
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infection with vancomycin-resistant enterococci. 
Secondly, antibiotics may favor the selection of 
inducible P-lactamase producing Gram-negative 
bacilli such as P. aeruginosa, E. cloacae, Serratia spp. and 
Citrobacter freundii. Using a prospective, case- 
controlled observational study, Jacobson et al. (1995) 
have recently examined the risk factors for the 
development of resistance to extended-spectrum 
cephalosporins in the Bush Group 1 (inducible 
AmpC) P-lactamase producing organisms [29]. Prior 
use and the mean number of antibiotics used were 
significantly greater for resistant compared to 
susceptible isolates (3.2 vs. 1.8; p < 0.032). Resistance 
was associated with prior use of ceftizoxime or 
cefotaxime (p = 0.008), ceftazidime (p = 0.004) and 
piperacillin (p = 0.001). In this study, there was also a 
linear relationship between the number of days of 
antibiotic therapy and the risk of developing 
resistance. 
In the EPIIC study, 62% of 10,038 patients were 
receiving antibiotics for either prophylaxis or 
treatment on the study day. The most frequently 
administered antibiotics were cephalosporins (44%) 
followed by broad-spectrum penicillins (24.3%), 
aminoglycosides (23.9%), metronidazole (17.1%), 
fluoroquinolones (1 1.9%) and glycopeptides (1 1.6%). 
Of the patients receiving antimicrobials, 5 1% received 
more than one agent. 
Antibiotic usage and prescribing policy play a very 
important role in the epidemiology of nosocomial 
infections in the ICU. A study from 1993 [30] found 
that, in patients who did not receive antibiotic 
treatment prior to their pneumonic episode, the 
predominant pathogens were methicilhn-susceptible 
S. aureus, H.  influenzae and S.  pneumoniae. In contrast, 
considering patients who had received antibiotic 
therapy prior to the onset of pneumonia, the 
predominant pathogens were P. aeruginosa, S. aureus 
and S .  marcescens (Table 1). Overall, a significant 
difference was seen in the prevalence of Gram- 
positive cocci, which represented 49.1% of isolates in 
the group with no prior exposure to antibiotics, 
compared with 13.4% of isolates in the group exposed 
to previous antibiotic therapy. In contrast, Gram- 
negative bacilli, excluding H .  influenzae, represented 
19.6% ofisolates in patients not exposed to antibiotics, 
compared with 69.2% of isolates from patients with 
prior antibiotic exposure. The major risk factor for 
mortality in ventilator-associated pneumonia (VAP) 
was prior antibiotic use (OR = 9.2), but when the 
etiological agent was included in the regression 
equation, prior antibiotic use was no longer a 
significant risk factor [30]. This demonstrated that the 
different distribution of microorganisms present in 
patients who had received prior antibiotic therapy was 
the true risk factor, and that a higher mortality rate 
was associated with certain high-risk pathogens such 
as P. aeruginosa [30]. 
In a recent study, the pathogens responsible for 
VAP were examined in relation to the duration of 
ventilation and prior antibiotic exposure [3 11. 
Pseudomonas spp., Acinetobacter spp. and MRSA were 
more prevalent in patients who were previously exposed 
to antimicrobials. In contrast, MRSA and S. pneumoniae 
were more frequently isolated from patients who had 
not received prior antibiotics. Prior antibiotic 
exposure &d not appear to affect the prevalence of 
Enterobacteriaceae or Haemophilus spp., but the 
frequency of isolation of Haemophilus spp. decreased 
markedly in patients who had been ventilated for 
longer than 7 days [31]. Furthermore, in a matched 
case-control study, the mortality rate for nosocomial 
Table 1 Microorganisms isolated from 129 episodes of ventilator associated pneumoniaa in relation to previous antibiotic use. 
Adapted &om Rello et al. with permission of Chest [30] 
Organism no. of isolates 
Previous antibioticb No antibiotic 
Gram-positive cocci 
S. aureus 6 22 
S. pneumoniae 0 5 
P .  aemginosa 21 3 
H. infuenzae 3 17 
Enterobacteriaceae 12 4 
Gram-negative bacilli 
a Patients from medical-surgical ICU. 
b Patients received broad-spectrum antibiotics for more than 48 h in the 10 days preceeding a pneumonic episode. 
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pneumonia caused by pathogens such as Pseudomonas 
spp. and Acinetobucter spp., was higher than for the 
more antibiotic-susceptible pathogens, with an 
attributable rate of up to 43%, compared with 27% for 
other pathogens [32]. In the study by Rello et al. [30], 
variables associated with mortality in VAP were found 
to be age (> 45 years), the use of corticosteroids, shock, 
hospital day of acquiring VAP > day 9, antecedent 
chronic obstructive pulmonary disease (COPD) and 
prior antibiotic use. 
The prognosis in patients with bacteremic sepsis 
depends on the severity of acute illness, underlying 
chronic diseases and complications associated with 
infection. In a cohort of 176 surgical ICU patients 
presenting with sepsis and positive blood cultures [33], 
independent predictors of mortality at  onset of sepsis 
were exposure to previous antibiotic therapy (OR = 
2.40, CI,, 1.59-3.62, p = 0.034), hypothermia (OR 
= 1.43, CI,, 1.04-2.44, p = 0.030), requirement for 
mechanical ventilation (OR = 2.97, CI,, 1.96-4.51, 
p = 0.009) and onset-of-sepsis APACHE I1 score 
(OR = 1.21, CI,, 1.13-1.29, p < 0.001). Vital 
organ dysfunction developing after the onset of sepsis 
influenced outcome markedly. Thus, exposure to 
antimicrobials at the time of bacterema is associated 
with poor outcome, even after adjustment for other 
factors. 
Catheterization 
A major factor responsible for infection in the ICU is the 
greater usage of multiple invasive devices, particularly 
in critically ill patients. A recent study found that 25% of 
episodes of bacteremia were due to catheter-associated 
infections and primary bacteremia accounted for 18% 
of episodes of severe sepsis [13]. Catheter-associated 
bloodstream infections are increasing in incidence and 
are frequently caused by coagulase-negative 
staphylococci (CNS) which enter frorn the patient’s 
skin on insertion or from flora on the hands of medical 
personnel during subsequent manipulation of the 
intravenous line. Indeed, recent data demonstrated that 
the proportion of CNS responsible for nosocomial 
bloodstream infections was more than twice that of 
CNS responsible for community-acquired infection 
[9]. The increased use of indwelling devices has also 
been shown to be a risk factor for the acquisition of 
nosocomial candidemia [34-361. 
CURRENT EPIDEMIOLOGY 
Over recent years, changes in the distribution of 
organisms and drug resistance patterns have emerged 
among nosocomial pathogens [32,37]. The distribution 
and frequency of pathogens vary, both with the site of 
infection and the hospital location. Surveillance 
information is therefore vital in order to determine 
local and national trends in the incidence of the major 
pathogens and their antimicrobial susceptibility [25]. 
Large epidemiological studies 
Results from the National Nosocomial Infection 
Surveillance (NNIS) study, generated by 80 medical 
centers in the USA from 1980-1992, indicate a trend 
towards fewer urinary tract infections and more 
bloodstream infections in the hospital environment 
[ l l ] .  This may be related to changes in urinary 
catheter care and to the increasing use of intravascular 
devices. Pneumonia and primary bacteremia were 
among the most serious hospital-acquired infections, 
accounting for greater than 15% and 13% of 
infections, respectively. The incidence of bacteremia 
increased from 7% in 1980 to 13% in 1992, whereas 
the incidence of urinary tract infections fell from 40% 
to 33% over the same time period. 
These findings were also confirmed in 
international studies [8]. O n  the day of the EPIIC 
study, the most prevalent ICU-acquired infection was 
pneumonia, which accounted for 47% of infections 
followed by lower respiratory tract infections other 
than pneumonia, urinary tract infections, bacteremia 
and wound infections (Figure 1) [8]. 
Distribution of pathogens 
In the NNIS study, among hospitals conducting ICU 
surveillance, the most common pathogens were 
P. aeruginosa (12%), S. aureus (12%), CNS (lo%), Cundida 
spp. (lo%), Enterobacter spp. (9%) and enterococci (9%). 
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Figure 1 Most frequently-reported ICU-acquired 
infections in the EPIIC study. From Vincent et al. [8]. 
(LRTI = lower respiratory tract infection bneumonia 
excluded), UTI = urinary tract infection). With permission 
of the American Medical Association. 
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Over this period there was an increase in Gram- 
positive organisms, particularly CNS. Small increases 
in the number of S. aureus, P. aeruginosa, enterococci 
and Enterobacter spp. also occurred. More recent data 
from the NNIS study indicate a further increase in 
CNS (from 9% in 1989 to 30% in 1992). The five 
leading pathogens isolated from different infection 
sites in the ICU are shown in Table 2 [ll]. 
In EPIIC, the most commonly reported pathogens 
in the ICU were S. aureus, P. aeruginosa, CNS, E. coli, 
enterococci, Acinetobacter spp., Mebsiellu spp., streptococci 
and Candida spp. In other epidemiologcal studies, 
Candida spp. has also been reported as a significant 
pathogen [38]. As in the NNIS study, the distribution 
and frequency of pathogens in EPIIC varied 
depending on the infection site. In the ICU, the main 
source of infection was from the respiratory tract since 
most patients were on assisted ventilation. 
EPIIC revealed a relatively low rate of laboratory- 
codinned bloodstream infections, which is in contrast to 
other studies [39]. Gram-positive organisms accounted 
for about 70% of the total number of isolates 
responsible for bacteremia. O f  these, CNS accounted 
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for 45% of isolates, followed by S .  aureus (21.9%) and 
enterococci (10.9%). The EPIIC study confirmed the 
results of other studies that have documented an 
increasing number of Gram-positive infections, 
particularly CNS. Enterobacteriaceae and P.  aertcginosa 
were also a frequent cause of bacteremia. 
These results are in keeping with those of a 
retrospective study [lo], examining trends in the 
prevalence of causative pathogens for nosocomial 
bloodstream infections at a single institution in a US 
referral hospital. Figure 2 shows that the rates of isolation 
of CNS (p < 0.001), enterococci (p < 0.001), 
Candida spp. (p = 0.001) and to a lesser extent, S. aureus 
(p = 0.009), increased between 1981 and 1992. There 
was also a linear increase in the number of polymicrobial 
infections. In contrast, the proportion of infections 
caused by Gram-negative bacilli, such as E. coli, 
Klebsiella spp., P. aeruginosa, Enterobacter spp. and 
S. marcescens decreased from 52% in 1980 to 29% in 
1992. The proportion of E. coli isolates halved (from 
13% to 6.5%) and P. aeruginosa isolates fell from 12% 
to 5%. The increase in Gram-positive isolates from 
42% to 54% does not appear particularly marked until 
Table 2 The five most common nosocomial pathogens, by site of infection, in the ICU. National Nosocomial Infection 
Surveillance (NNIS), October 1986-December 3 990. Adapted from Jarvis and Martone= [ l l ]  
~~~ ~~ 
Site, organism Frequency (%) 
Blood 
CNS 
S. aureus 
Enterococci 
Candida spp. 
Enterobacter spp. 
Surgical wound 
Enterococci 
CNS 
S. aureus 
Enterobacter spp. 
P .  aeruginosa 
Respiratory tract 
P.  aeruginosa 
S. aureus 
Entero bacter spp . 
Acinetobacter spp. 
K. pneumoniae 
Urinary tract 
Candida spp. 
E. coli 
Enterococci 
P. aewginosa 
Enterobacter spp. 
28.2 
16.1 
12.0 
10.2 
5.3 
15.8 
13.8 
11.7 
10.3 
9.5 
20.8 
17.1 
11.1 
6.4 
5.6 
25.0 
17.5 
13.0 
11.3 
6.1 
aData collected from adult and pediatric ICUs. 
CNS = coagulase-negative staphylococci. 
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Pathogen-specific rates: 
No. of isolates per 10,000 patient-days. 
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Figure 2 Secular trends in the rates of isolation of selected bloodstream isolates. From Pittet and Wenzel [lo]. With permission 
of the American Medical Association 
it is realised that the total number of pathogens 
isolated in 1990-1992 (1,291) was almost twice that 
isolated in 1981-1983 (663). The actual number of 
Gram-positive cocci bloodstream isolates increased 
2.5-fold, whereas the number of isohtes of aerobic 
Gram-negative bacilli remained constaint. 
Similarly, a large study of 980 episodes of 
bacteremia recorded between 1979 and 1989 at a 
1,300-bed university hospital in Berlin, showed that 
bacteremia due to Gram-negative organisms decreased 
consistently from 45% in 1979 to 39.8% in 1989. In 
contrast, bacteremia due to Gram-positive bacteria 
decreased from 47.3% in 1979 to 43.7% in 1986, but 
increased again to 51.2% in 1989 [40]. The two major 
pathogens responsible for the increase in numbers of 
Gram-positive cocci isolated are CNS and 
enterococci. 
Coagulase-negative staphylococci (CNS) 
The greater recognition and reporting of CNS as 
clinically relevant pathogens, together with routine 
blood cultures are thought to be contributory factors 
to their increase in incidence [10,41,42]. However, 
controversy exists over whether CNS are true 
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pathogens or merely contaminants of blood cultures. 
CNS bacteremia has been shown to have an 
attributable mortality of 13.6% which, although lower 
than that for candidemia (36%) and enterococcal 
bacteremia (31%), is still in excess of that due to 
underlying disease alone [43]. However, in a recent 
multicenter study of bacteremia and severe sepsis in 
adults, Gram-positive organisms other than CNS were 
among factors which increased the risk of death, 
indicating that CNS are associated with low 
pathogenicity [13]. 
It has been recommended that two consecutive 
blood cultures from which CNS are isolated are 
required before this organism is recognized as the 
causative pathogen, whereas other reports have 
indicated that a single blood culture positive for CNS 
is frequently associated with clinically relevant episodes 
of bloodstream infection [29,44]. Henvaldt et al. 
used four criteria to define true bloodstream infections 
after isolation of CNS: temperature of 2 38°C; 
administration of appropriate treatment; criteria for 
nosocomial bloodstream infection were met; at least 
one clinical sign or laboratory value consistent with 
infection [45]. Only 60 (26.4%) of 227 episodes met 
these stringent criteria. While it is commonly 
recognized that patients admitted to the ICU may be 
at increased risk of developing CNS bloodstream 
infection, only 7.7% of the episodes involving a 
positive Isolator@ culture from the surgical ICU met 
the definition of infection. This may, however, have 
been due to the fact that most of the Isolator@ cultures 
were actually surveillance cultures performed to study 
catheter-associated infection and represent a major 
bias [44]. 
Enterococci 
Enterococci are also significant nosocomial pathogens, 
being isolated with increasing frequency in the ICU 
and the incidence of vancomycin resistance among 
enterococci is also increasing [10,11,25]. Results from 
the NNIS survey in 1992, found that enterococci 
were responsible for 15.8% of surgical wound 
infections, 13% of urinary tract infections and 12% of 
blood infections [ll]. The clinical significance of 
enterococcal bacteremia not associated with 
endocarditis has been controversial. However, it is 
now agreed that enterococcal isolates fiom the blood 
may be predictive of high mortality. Moreover, a 
significant association between appropriate antibiotic 
therapy and reduced mortality has been shown [46]. 
The attributable mortality from nosocomial 
bacteremia was estimated to be 32% in a matched 
case-control study. In addition, mortality has been 
recently shown to be higher among bacteremic patients 
infected with Enterococcus faecium than among those 
infected with E. faecalis [47]. A recent case-control 
study, suggests that vancomycin-resistant bacteremia is 
associated with high rates of severe sepsis and septic 
shock. In this study the mortality attributable to 
vancomycin-resistant enterococci (VRE) was 37% 
(95% confidence interval, 10-64%) [48]. 
Emerging pathogens 
Several organisms are emerging as nosocomial 
pathogens and may establish themselves as serious 
causes of infection [25,38]. Many institutions report 
Stenotrophomonas maltophilia, Acinetobacter spp. and 
Candida spp. as significant pathogens [10,25,38]. 
Acinetobacter spp. have been implicated in a variety of 
nosocomial infections, but mostly in nosocomial 
pneumonia. Nosocomial candidemia has become an 
important infection because of both an apparent 
increasing incidence and a high fatality rate. The 
excess mortality attributable to candidemia has been 
estimated at 38% [34], and it is k=commended that all 
patients with candidemia receive antifungal therapy 
[49]. The main risk factors for nosocomial candidemia 
in non-neutropenic patients are: recent use of 
antibiotics; presence of a central venous catheter; 
hyperalimentation; abdominal and thoracic surgery; 
and recent use of corticosteroids. The prevalence of 
Candida non-albicans seems to be increasing. Indeed, 
in a recent study it was found that Candida non-albicans 
represented 77% of the 73 episodes of candidemia at 
hospitals where azoles were rarely used [38]. 
Severe sepsis and septic shock 
The classification of severe infection-related syndromes 
has been recently revised to better categorize the 
patients affected and reflect the range of severity 
encountered [50,51]. Patients with a combination of 
fever or hypothennia, tachycardia, tachypnea or 
changes in blood leukocyte count that can be 
attributed to a documented infectious process are now 
defined as having a clinical syndrome of ‘systemic 
inflammatory response’ or SIRS [39]. More severe 
cases are characterized by the combination of sepsis 
with signs of organ dysfunction, whde ‘septic shock’ 
refers to septic patients with persisting hypotension 
and/or organ dysfunction despite adequate 
resuscitation; these conditions are associated with 
mortality rates ranging from 30-60%. 
In a parallel study of 85,750 adrmssions to ICUs 
and wards of 24 hospitals in France [13], the rate of 
bacteremia was 9.8/1000 admissions, and that of 
severe sepsis 6/1000. Bacteremia was eight times more 
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frequent in ICUs (69/1000) than in wards (8.2/1000) 
and severe sepsis 32 times higher (119/1000 vs. 
2.9/1000). Nosocomial episodes occurred in 41/1000 
ICU patients, and bacteremia was associated with 
severe sepsis in two thirds of episodes. In ICUs, the 
occurrence of severe sepsis during bacteremia was 
associated with age, the admission category and the 
source of bacteremia (with a reduced risk in patients 
with primary or catheter-related bacteremia, or due to 
CNS). The risk factor for death after bacteremia 
increased with age, a rapidly or ultimately fatal 
underlying disease and the presence of severe sepsis, 
shock and infection caused by Gram-positive 
organisms other than CNS (Table 3). 
A two month prospective study examined the 
incidence, risk factors and outcome of severe sepsis in 
ICU patients [9], and included more than 11,000 
admissions to 170 ICUs. Of these patients, 1052 had 
clinically-suspected severe sepsis which represented 9% 
of ICU admissions, and severe sepsis with associated 
microbiological documentation was found in 6.3%. In 
this study, 48% of the infections were community- 
acquired and 52% were nosocomial, including 25% 
ICU-acquired episodes. The predominant sources of 
infection were pulmonary and abdominal. Risk factors 
associated with documented severe sepsis were: age 
(> 60 years); hospital size (> 400 beds); unscheduled 
admissions; chronic liver failure; immunosuppression 
and rapidly fatal or ultimately fatal underlying disease. 
The crude 28-day mortality rate in patients with 
documented severe sepsis or septic shock was 56%, 
and that in patients with culture-negative sepsis was 
similar, 60%. Overall, patients with clinically-suspected 
severe sepsis had similar risk factors and mortality rates 
whether or not there was a documented infection. 
Distribution of pathogens 
In severe sepsis and septic shock, significant 
differences occur in the frequency of isolation of 
pathogens in community-acquired and hospital- 
acquired infection @ < 0.001) (Table 4). Overall, 
the proportion of infections caused by Gram-negative 
bacilli and the proportion of polymicrobial infections 
were higher for patients with ICU-acquired sepsis 
than those with severe sepsis on admission to the ICU. 
Patients with hospital-acquired sepsis had a higher 
Table 3 Risk factors for death in 832 patients with bacteremia: multivariate analysis. Adapted (with permission) from Bmn- 
Buisson et al. [13] 
Risk factor Relative risk (95% CI) p value 
Age ( F S )  
< 50 
50-59 
60-69 
70-79 
280 
Absent or nonfatal 
Ultimately fatal 
Rapidly fatal 
Source of bacteremia 
Urinary tract 
Abdominal 
Respiratory tract 
Intravascular catheter 
Other sources 
Multiple sources 
Underlying disease 
Severe sepsis 
Shock 
Organisms 
Gram-negative 
Gram-positive 
Other organisms 
Mixed organisms 
1 
1.1 (0.6-1.9) 
1.5 (1.0-2.4) 
2.1 (1.4-3.3) 
2.4 (1.6-3.7) 
1 
1.4 (1.0-2.0) 
3.6 (2.&5.0) 
0.6 (0.41 .O) 
- 
- 
3.5 (2.5-5.0) 
1.5 (1.0-2.2) 
1 
1.8 (1.3-2.5) 
1.6 (1.0-2.9) 
3.6 (2.2-5.8) 
< 0.001 
co.001 
0.03 
<0.001 
0.03 
<0.001 
~~ ~~ ~~ 
When specific organisms were substituted and sources of infection were not used in the analysis, risk factors for mortality were: age (p < 0.001); 
underlying disease (p < 0,001); nosocomial infection (OR = 1.3; p = 0.04); bacteremia caused by S. aureus (OR = 1.6; p = 0.005) or by 
Gram-positive organisms other than coagulase negative staphylococci (OR = 1.4; p = 0.04). polymicrobial bacteremia (OR = 1.8; p = 0.008) 
relative to other organisms. 
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prevalence of isolation of P. aeruginosa (13.5%), 
Enterobacteriaceae (31.8%) and CNS (4.7%) than 
patients with community-acquired sepsis (4.9%, 27.3% 
and 2. I%, respectively). Conversely, S. pneurnoniae 
and anaerobes were isolated more frequently from 
patients with community-acquired severe sepsis. For 
patients with bacteremia, 39% had Gram-positive 
infections, 35% had Gram-negative infections and 
21% had polymicrobial infections. In the hospital 
survey, Gram-positive and Gram-negative organisms 
accounted for 49% and 42% of episodes of bacteremia, 
respectively, while 5% were mixed-organism 
bacteremias. The predominant pathogens were S. aweus 
(19% of episodes), CNS (11%) and enterococci (5.5%). 
The high frequency of Gram-positive organisms in 
patients with sepsis syndrome was confirmed in two 
recent studies of the efficacy of monoclonal antibody 
to human tumor necrosis factor alpha [52,53]. In both 
studies, Gram-positive organisms were nearly as fkequent 
as Gram-negative organisms and the percentage of 
patients with mixed pathogens ranged from 10.3-21%, 
according to the studies and treatment (Table 5). This 
contrasts with earlier studies in which Gram-negative 
bacteria were the predominant pathogens in the blood 
Some studies have also found that sepsis can be 
associated with negative blood cultures. In one study, 
mortality along SIRS was examined in more than 
3700 patients at a single center [55]. As the population 
progressed from sepsis to septic shock, an increasing 
proportion of patients developed acute respiratory 
distress syndrome, disseminated intravascular 
coagulation, acute renal failure and shock. Positive 
blood cultures were found in 17% of patients with 
sepsis, in 25% with severe sepsis and in 69% with 
septic shock. Mortality in sepsis appeared to be lower 
(541. 
Table 4 The prevalence of pathogens in community-acquired and hospital-acquired severe sepsis and septic shock in adults 
in the ICU. Adapted from Brun-Buisson et al. (91. With permission of the American M e d d  Association 
Organism Source of infection, frequency of isolation (%) 
Community Hospital 
E .  coli 
S .  aureus 
P .  aeruginosa 
S.  pneumoniae 
Anaerobes 
Enterococci 
Enterobacter/Citvobacter/Serratia 
KIebsielia /Proleus 
Coagnlase-negative staphylococci 
18.2 
11.2 
4.9 
11.4 
7.5 
7.5 
2.6 
6.5 
2.1 
14.2 
18.2 
13.5 
1.7 
3.5 
5.9 
6.6 
11 
4.7 
Table 5 Distribution of causative organisms in two recent controlled trials of monoclonal antibody to human tumor necrosis 
factor-alpha in patients with sepsis. Selected from Abraham et al. 1995; Cohen & Carlet 1996 [52,53] 
Norasept 
( n  = 725)a 
Intersept 
(n 322)b 
~~~~~ ~ 
Gram-negative (%) 
Gram-positive (%) 
Gram-positive & Gram-negative (“A) 
Fungi 
Other/other combinations 
40 
37 
11.5 
5 
6.5 
29 
24 
22 
2 
23 
a A l l  randonlized patients with microbiological determination. 
bOnly shock patients with nucrobiologicd documentation. 
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in patients with negative blood cultures than in those 
with positive blood cultures (10% vs. 16%), but the 
difference was not statistically significant. There was 
no difference, however, in mortality between septic 
shock with or without positive blood cultures in this 
study, a finding observed in other studies [13,56,57]. 
Importantly, about 50% of the patients with severe 
sepsis or septic shock had a negative blood culture 
[13,57] and mortality rates in patients with septic 
shock with or without positive blood cultures were 
similar in most studies [6,13,54-581. 
CONCLUSIONS 
Although the major pathogens responsible for 
hospital-acquired infections vary depending on the 
site of infection, the results from these studies confirm 
that S .  nureus, E .  coli and P. neruxinosa rernain important 
iiosocomial pathogens and that CNS and enterococci 
are pathogens of growing importance. 
The increasing incidence of Grain-positive isolates 
found in such studies emphasizes the need for broad- 
spectrum antimicrobial agents to be equally effective 
against Gram-positive and Gram-negative bacteria when 
empirical antibiotic therapy in severe infections in ICU 
patients is considered. Several studies have indicated 
that severe and frequently fatal septic conditions are 
commonly associated with negative blood cultures, 
forcing the clinician to start empirical antimicrobial 
therapy based on individual experieiice and knowledge 
of the local epidemiological trends. 
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